These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 320832)

  • 41. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of lithium carbonate in psychiatric therapy. Apropos of 85 cases].
    Darcourt G
    Psychopharmacologie; 1973; 0(0):26-42. PubMed ID: 4599704
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics and acute side-effects of nifedipine given as slow-release tablets or liquid-filled capsules.
    Saano V; Raatikainen O; Paronen P; Komulainen H
    Int J Clin Pharmacol Res; 1989; 9(4):247-54. PubMed ID: 2777428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absorption and side-effects after peroral administration of sustained release iron tablets. Ferro-Retard compared with Ferronicum and Duroferon Duretter.
    Levy F; Anderson P; Ekren T
    Acta Med Scand; 1978; 204(4):303-10. PubMed ID: 358765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and evaluation of sustained-release tablets of lithium in a fat matrix and its bioavailability in humans.
    Llabrés M; Fariña JB
    J Pharm Sci; 1991 Nov; 80(11):1012-6. PubMed ID: 1815050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How does the patient prefer his lithium treatment?
    Vestergaard P
    Pharmacopsychiatry; 1985 May; 18(3):223-4. PubMed ID: 4011670
    [No Abstract]   [Full Text] [Related]  

  • 48. Absorption from different types of iron tablets - correlation between serum iron increase in total absorption of iron.
    Ekenved G
    Scand J Haematol Suppl; 1976; 28():51-63. PubMed ID: 1064902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of lithium adverse effects between a short-term (Quilonum) and a depot preparation (Lithium Duriles)].
    Matussek N; von Hessling P
    Nervenarzt; 1971 Jul; 42(7):376-8. PubMed ID: 5561070
    [No Abstract]   [Full Text] [Related]  

  • 50. Alprenolol in angina pectoris. A comparative study of the tablet form and slow-release formulation.
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Med J Aust; 1975 Oct; 2(17):668-73. PubMed ID: 1107769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo drug release from hydrophilic dextran tablets capable of forming polyion complex.
    Miyazaki Y; Tanaka Y; Yakou S; Takayama K
    J Control Release; 2006 Aug; 114(1):47-52. PubMed ID: 16824636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liquid lithium vs. solid lithium: an open, cross-over, pilot study comparing oral preparations.
    Heiman MF; Schwabach G; Tupin J
    Dis Nerv Syst; 1976 Jan; 37(1):9-11. PubMed ID: 1106967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of standard and sustained-release (Priadel) lithium carbonate preparations.
    Johnson G; Hunt G; Jackson D; Richards T; Kwan E
    Med J Aust; 1979 Oct; 2(7):382. PubMed ID: 390347
    [No Abstract]   [Full Text] [Related]  

  • 54. [New sustained release form of lithium sulfate].
    Ventouras K; Kick P; Buri P
    Schweiz Med Wochenschr; 1973 Jun; 103(24):878-81. PubMed ID: 4712019
    [No Abstract]   [Full Text] [Related]  

  • 55. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit).
    Bennie EH; Manzoor AK; Scott AM; Fell GS
    Br J Clin Pharmacol; 1977 Aug; 4(4):479-83. PubMed ID: 901741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
    Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
    J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of lithium in mania.
    Crammer JL
    Compr Ther; 1975 Jul; 1(3):74-8. PubMed ID: 767044
    [No Abstract]   [Full Text] [Related]  

  • 59. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
    Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
    J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lithium absorption from sustained-release tablets (Duretter).
    Amdisen A; Sjögren J
    Acta Pharm Suec; 1968 Nov; 5(5):465-72. PubMed ID: 5732567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.